These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24587105)

  • 21. The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.
    García-Torres D; Fierke CA
    J Biol Chem; 2019 Aug; 294(31):11793-11804. PubMed ID: 31197034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
    Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
    Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis.
    Sequeira L; Dubyk CW; Riesenberger TA; Cooper CR; van Golen KL
    Clin Exp Metastasis; 2008; 25(5):569-79. PubMed ID: 18461284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
    Zhong WB; Wang CY; Chang TC; Lee WS
    Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farnesyl transferase inhibitor FTI-277 inhibits breast cell invasion and migration by blocking H-Ras activation.
    Lee KH; Koh M; Moon A
    Oncol Lett; 2016 Sep; 12(3):2222-2226. PubMed ID: 27602167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
    Collisson EA; Kleer C; Wu M; De A; Gambhir SS; Merajver SD; Kolodney MS
    Mol Cancer Ther; 2003 Oct; 2(10):941-8. PubMed ID: 14578459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a farnesol analog as a Ras function inhibitor using both an in vivo Ras activation sensor and a phenotypic screening approach.
    Srinivasan K; Subramanian T; Spielmann HP; Janetopoulos C
    Mol Cell Biochem; 2014 Feb; 387(1-2):177-86. PubMed ID: 24194124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor.
    Kusama T; Mukai M; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
    Clin Exp Metastasis; 2003; 20(6):561-7. PubMed ID: 14598891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
    Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
    Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific role of RhoC in tumor invasion and metastasis.
    Lang S; Busch H; Boerries M; Brummer T; Timme S; Lassmann S; Aktories K; Schmidt G
    Oncotarget; 2017 Oct; 8(50):87364-87378. PubMed ID: 29152087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.
    Collisson EA; Carranza DC; Chen IY; Kolodney MS
    J Invest Dermatol; 2002 Nov; 119(5):1172-6. PubMed ID: 12445208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity.
    Peterson YK; Kelly P; Weinbaum CA; Casey PJ
    J Biol Chem; 2006 May; 281(18):12445-50. PubMed ID: 16517596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Farnesol-mediated shift in the metabolic origin of prenyl groups used for protein prenylation in plants.
    Huchelmann A; Brahim MS; Gerber E; Tritsch D; Bach TJ; Hemmerlin A
    Biochimie; 2016 Aug; 127():95-102. PubMed ID: 27138105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
    Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
    Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RHO GTPase signaling for axon extension: is prenylation important?
    Samuel F; Hynds DL
    Mol Neurobiol; 2010 Oct; 42(2):133-42. PubMed ID: 20878268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi: cloning, trans-splicing, and prenylation studies.
    Nepomuceno-Silva JL; Yokoyama K; de Mello LD; Mendonca SM; Paixão JC; Baron R; Faye JC; Buckner FS; Van Voorhis WC; Gelb MH; Lopes UG
    J Biol Chem; 2001 Aug; 276(32):29711-8. PubMed ID: 11359782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
    Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.